Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statement of Changes in Stockholders' Equity (Unaudited)

v3.21.1
Condensed Consolidated Statement of Changes in Stockholders' Equity (Unaudited) - USD ($)
Common Stock [Member]
Additional Paid-In Capital [Member]
Common Stock Dividend Payable [Member]
Accumulated Deficit [Member]
Total
Balance at Dec. 31, 2019 $ 549 $ 18,994,008 $ 3 $ (10,982,010) $ 8,012,550
Balance, shares at Dec. 31, 2019 5,486,595        
Stock-based compensation 98,663 98,663
Transaction costs related to the 2020 underwritten public offering (2,806) (2,806)
Net loss (874,336) (874,336)
Balance at Mar. 31, 2020 $ 549 19,089,865 $ 3 (11,856,346) 7,234,071
Balance, shares at Mar. 31, 2020 5,486,595        
Balance at Dec. 31, 2020 $ 1,419 48,333,857   (25,395,798) 22,939,478
Balance, shares at Dec. 31, 2020 14,187,984        
Stock-based compensation $ 1 308,297   308,298
Stock-based compensation, shares 12,500        
Equity issued to a consultant as a prepayment for services 312,293   312,293
Shares issued in private placement, net of transaction costs $ 132 9,875,418   9,875,550
Shares issued in private placement, net of transaction costs, shares 1,321,132        
Net loss       (2,099,481) (2,099,481)
Balance at Mar. 31, 2021 $ 1,552 $ 58,829,865   $ (27,495,279) $ 31,336,138
Balance, shares at Mar. 31, 2021 15,521,616